Trials / Completed
CompletedNCT01106274
The Effects of Riboflavin/ Ultraviolet-A Corneal Cross-linking on the Signs and Symptoms of Bullous Keratopathy
Study of the Effects of Riboflavin/ Ultraviolet-A Corneal Cross-linking
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Mashhad University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Recently, riboflavin (0.1%) and ultraviolet-A (UVA) collagen cross-linking (C3R) has shown potential to improve the signs and symptoms of bullous keratopathy .The objective of this study is to demonstrate the effects of C3R to treat bullous keratopathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | ultraviolet-A | Corneal cross linking (C3R) with riboflavin and ultraviolet-A (UVA, 370 nm, 3mW/cm2) for 30 min |
Timeline
- Start date
- 2008-11-01
- Completion
- 2009-09-01
- First posted
- 2010-04-19
- Last updated
- 2010-04-19
Source: ClinicalTrials.gov record NCT01106274. Inclusion in this directory is not an endorsement.